(BMI) Badger Meter - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0565251081
Stock: Flow Meters, Software, Sensors, Data, Communication
Total Rating 30
Risk 76
Buy Signal -1.23
| Risk 5d forecast | |
|---|---|
| Volatility | 30.4% |
| Relative Tail Risk | -5.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.77 |
| Alpha | -52.98 |
| Character TTM | |
|---|---|
| Beta | 1.092 |
| Beta Downside | 1.213 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.92% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: BMI Badger Meter March 04, 2026
Badger Meter, Inc. (BMI) manufactures and sells solutions for flow measurement, quality, control, and communication globally. A significant portion of its business focuses on smart metering solutions and software for municipal water utilities. This sector is experiencing growth due to increasing demand for efficient water management and conservation.
BMI also provides flow instrumentation products, including meters and valves, to OEMs for integration into their systems. These products measure various fluids, such as water, air, and steam, across diverse industrial applications. The companys offerings extend to advanced cellular and radio endpoints, water quality monitoring solutions, and leak detection sensors. The BEACON software suite provides cloud-hosted tools for alerts and consumer water usage management, reflecting a trend towards digital transformation in utility services.
The company serves water utilities, commercial, and industrial clients, offering comprehensive support services. Its sales channels include direct employees, resellers, and representatives. Further research on platforms like ValueRay can provide deeper insights into BMIs market position and financial performance.
Headlines to watch out for
- Municipal utility smart water meter adoption drives revenue
- Industrial flow instrumentation demand impacts sales
- Raw material costs influence profit margins
- Regulatory mandates for water conservation boost demand
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 141.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: 38.88% < 20% (prev 51.04%; Δ -12.17% < -1%) |
| CFO/TA 0.19 > 3% & CFO 183.7m > Net Income 141.6m |
| Net Debt (-226.0m) to EBITDA (221.9m): -1.02 < 3 |
| Current Ratio: 3.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.5m) vs 12m ago 0.59% < -2% |
| Gross Margin: 41.68% > 18% (prev 0.40%; Δ 4.13k % > 0.5%) |
| Asset Turnover: 102.4% > 50% (prev 101.2%; Δ 1.18% > 0%) |
| Interest Coverage Ratio: -137.5 > 6 (EBITDA TTM 221.9m / Interest Expense TTM -1.36m) |
Altman Z'' 8.73
| A: 0.37 (Total Current Assets 507.1m - Total Current Liabilities 150.7m) / Total Assets 973.6m |
| B: 0.66 (Retained Earnings 645.9m / Total Assets 973.6m) |
| C: 0.21 (EBIT TTM 187.3m / Avg Total Assets 895.0m) |
| D: 2.62 (Book Value of Equity 683.1m / Total Liabilities 260.3m) |
| Altman-Z'' Score: 8.73 = AAA |
Beneish M -2.51
| DSRI: 1.20 (Receivables 112.4m/84.3m, Revenue 916.7m/826.6m) |
| GMI: 0.96 (GM 41.68% / 39.83%) |
| AQI: 1.61 (AQ_t 0.40 / AQ_t-1 0.25) |
| SGI: 1.11 (Revenue 916.7m / 826.6m) |
| TATA: -0.04 (NI 141.6m - CFO 183.7m) / TA 973.6m) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of BMI shares?
As of March 12, 2026, the stock is trading at USD 146.84 with a total of 167,921 shares traded.
Over the past week, the price has changed by -1.52%, over one month by -6.18%, over three months by -19.28% and over the past year by -28.31%.
Over the past week, the price has changed by -1.52%, over one month by -6.18%, over three months by -19.28% and over the past year by -28.31%.
Is BMI a buy, sell or hold?
Badger Meter has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold BMI.
- StrongBuy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 178 | 21.2% |
| Analysts Target Price | 178 | 21.2% |
BMI Fundamental Data Overview March 11, 2026
P/E Trailing = 31.2192
P/E Forward = 29.5858
P/S = 4.8076
P/B = 6.1178
P/EG = 3.1536
Revenue TTM = 916.7m USD
EBIT TTM = 187.3m USD
EBITDA TTM = 221.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -226.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.18b USD (4.41b + (null Debt) - CCE 226.0m)
Interest Coverage Ratio = -137.5 (Ebit TTM 187.3m / Interest Expense TTM -1.36m)
EV/FCF = 24.64x (Enterprise Value 4.18b / FCF TTM 169.7m)
FCF Yield = 4.06% (FCF TTM 169.7m / Enterprise Value 4.18b)
FCF Margin = 18.51% (FCF TTM 169.7m / Revenue TTM 916.7m)
Net Margin = 15.45% (Net Income TTM 141.6m / Revenue TTM 916.7m)
Gross Margin = 41.68% ((Revenue TTM 916.7m - Cost of Revenue TTM 534.6m) / Revenue TTM)
Gross Margin QoQ = 42.13% (prev 40.67%)
Tobins Q-Ratio = 4.29 (Enterprise Value 4.18b / Total Assets 973.6m)
Interest Expense / Debt = unknown (Interest Expense 205k / Debt none)
Taxrate = 24.79% (11.1m / 44.6m)
NOPAT = 140.9m (EBIT 187.3m * (1 - 24.79%))
Current Ratio = 3.36 (Total Current Assets 507.1m / Total Current Liabilities 150.7m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -1.02 (Net Debt -226.0m / EBITDA 221.9m)
Debt / FCF = -1.33 (Net Debt -226.0m / FCF TTM 169.7m)
Total Stockholder Equity = 683.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.83% (Net Income 141.6m / Total Assets 973.6m)
RoE = 20.71% (Net Income TTM 141.6m / Total Stockholder Equity 683.8m)
RoCE = 22.76% (EBIT 187.3m / Capital Employed (Total Assets 973.6m - Current Liab 150.7m))
RoIC = 20.60% (NOPAT 140.9m / Invested Capital 683.8m)
WACC = 9.94% (E(4.41b)/V(4.41b) * Re(9.94%) + (debt-free company))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF] Terminal Value 75.22% ; FCFF base≈158.7m ; Y1≈195.8m ; Y5≈333.4m
[DCF] Fair Price = 146.0 (EV 4.03b - Net Debt -226.0m = Equity 4.26b / Shares 29.2m; r=9.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 95.09 | EPS CAGR: 25.25% | SUE: -0.19 | # QB: 0
Revenue Correlation: 96.17 | Revenue CAGR: 14.60% | SUE: -1.63 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.27 | Chg7d=-0.108 | Chg30d=-0.111 | Revisions Net=-6 | Analysts=11
EPS current Year (2026-12-31): EPS=5.12 | Chg7d=+0.000 | Chg30d=-0.033 | Revisions Net=-10 | Growth EPS=+6.8% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=5.56 | Chg7d=+0.000 | Chg30d=+0.016 | Revisions Net=-4 | Growth EPS=+8.8% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 9.9% - Earnings Yield 3.2%)
[Growth] Growth Spread = -3.5% (Analyst 3.2% - Implied 6.7%)
P/E Forward = 29.5858
P/S = 4.8076
P/B = 6.1178
P/EG = 3.1536
Revenue TTM = 916.7m USD
EBIT TTM = 187.3m USD
EBITDA TTM = 221.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -226.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.18b USD (4.41b + (null Debt) - CCE 226.0m)
Interest Coverage Ratio = -137.5 (Ebit TTM 187.3m / Interest Expense TTM -1.36m)
EV/FCF = 24.64x (Enterprise Value 4.18b / FCF TTM 169.7m)
FCF Yield = 4.06% (FCF TTM 169.7m / Enterprise Value 4.18b)
FCF Margin = 18.51% (FCF TTM 169.7m / Revenue TTM 916.7m)
Net Margin = 15.45% (Net Income TTM 141.6m / Revenue TTM 916.7m)
Gross Margin = 41.68% ((Revenue TTM 916.7m - Cost of Revenue TTM 534.6m) / Revenue TTM)
Gross Margin QoQ = 42.13% (prev 40.67%)
Tobins Q-Ratio = 4.29 (Enterprise Value 4.18b / Total Assets 973.6m)
Interest Expense / Debt = unknown (Interest Expense 205k / Debt none)
Taxrate = 24.79% (11.1m / 44.6m)
NOPAT = 140.9m (EBIT 187.3m * (1 - 24.79%))
Current Ratio = 3.36 (Total Current Assets 507.1m / Total Current Liabilities 150.7m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -1.02 (Net Debt -226.0m / EBITDA 221.9m)
Debt / FCF = -1.33 (Net Debt -226.0m / FCF TTM 169.7m)
Total Stockholder Equity = 683.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.83% (Net Income 141.6m / Total Assets 973.6m)
RoE = 20.71% (Net Income TTM 141.6m / Total Stockholder Equity 683.8m)
RoCE = 22.76% (EBIT 187.3m / Capital Employed (Total Assets 973.6m - Current Liab 150.7m))
RoIC = 20.60% (NOPAT 140.9m / Invested Capital 683.8m)
WACC = 9.94% (E(4.41b)/V(4.41b) * Re(9.94%) + (debt-free company))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF] Terminal Value 75.22% ; FCFF base≈158.7m ; Y1≈195.8m ; Y5≈333.4m
[DCF] Fair Price = 146.0 (EV 4.03b - Net Debt -226.0m = Equity 4.26b / Shares 29.2m; r=9.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 95.09 | EPS CAGR: 25.25% | SUE: -0.19 | # QB: 0
Revenue Correlation: 96.17 | Revenue CAGR: 14.60% | SUE: -1.63 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.27 | Chg7d=-0.108 | Chg30d=-0.111 | Revisions Net=-6 | Analysts=11
EPS current Year (2026-12-31): EPS=5.12 | Chg7d=+0.000 | Chg30d=-0.033 | Revisions Net=-10 | Growth EPS=+6.8% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=5.56 | Chg7d=+0.000 | Chg30d=+0.016 | Revisions Net=-4 | Growth EPS=+8.8% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 9.9% - Earnings Yield 3.2%)
[Growth] Growth Spread = -3.5% (Analyst 3.2% - Implied 6.7%)